Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Natural Evolution and Heterogeneity of Neuropsychiatric Symptoms Across Neurocognitive Disorders: A Systematic Review and Meta-Analysis of Longitudinal Studies

by jlohrconsulting | Oct 21, 2025 | Uncategorized

Int J Geriatr Psychiatry. 2025 Oct;40(10):e70169. doi: 10.1002/gps.70169. ABSTRACT OBJECTIVES: Neuropsychiatric symptoms (NPS) are common and burdensome manifestations of neurocognitive disorders but the characterization of their natural evolution over time is...

Recommandation sur l’utilisation d’un instrument de dépistage de la dépression chez les adultes

by jlohrconsulting | Oct 21, 2025 | Uncategorized

CMAJ. 2025 Oct 19;197(35):E1154-E1167. doi: 10.1503/cmaj.250237-f. ABSTRACT CONTEXTE: La dépression perturbe le ressenti, la pensée et le comportement; elle est associée à une altération du fonctionnement social et professionnel, et elle peut s’accompagner d’idées...

Recommendation on screening adults for depression using a screening tool

by jlohrconsulting | Oct 21, 2025 | Uncategorized

CMAJ. 2025 Oct 19;197(35):E1132-E1143. doi: 10.1503/cmaj.250237. ABSTRACT BACKGROUND: Depression negatively affects how a person feels, thinks, or behaves; is associated with impaired functioning in social and work settings; and can be associated with thoughts of...

Schizophrenia Genetics Modulates Clinical Depressive Features

by jlohrconsulting | Oct 21, 2025 | Uncategorized

Am J Med Genet B Neuropsychiatr Genet. 2025 Oct 20. doi: 10.1002/ajmg.b.33066. Online ahead of print. ABSTRACT Schizophrenia (SCZ) genetic liability, quantified by polygenic scores (PGS), may influence clinical phenotypes in major depressive disorder (MDD). We...

Examining Seizure Documentation Practices by Primary Care Clinicians

by jlohrconsulting | Oct 21, 2025 | Uncategorized

J Am Board Fam Med. 2025 Oct 20. doi: 10.3122/jabfm.2024.240318R1. Online ahead of print. ABSTRACT BACKGROUND: Primary care clinicians (PCCs) frequently report low levels of comfort in managing seizure disorders, despite their essential role in caring for patients...

Evaluation of the Wisdom Enhancement Timeline approach for post-stroke depression using a single-case experimental design

by jlohrconsulting | Oct 21, 2025 | Uncategorized

Behav Cogn Psychother. 2025 Oct 21:1-14. doi: 10.1017/S1352465825101124. Online ahead of print. ABSTRACT BACKGROUND: Approximately 24% of stroke survivors develop post-stroke depression (PSD), which is associated with poor psychological recovery, identity disruption,...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments